Robert Whitfield MDAmerica's Breast Implant Illness Expert™

Breast Implant Risks: What You Need to Know (2024)

18 Jun 2025 · 1 min

Watch on YouTube

0:48

Excerpt from a YouTube video featuring Robert Whitfield MD discussing clinical risks of breast implants in cancer patients receiving adjuvant treatments (chemotherapy). The speaker relates recurrent postoperative infections and admissions for IV antibiotics in patients with implants, and recommends considering fat transfer over implants when only modest size increase is desired due to unfavorable risk–benefit for implants in that context.

Chapters

And because we did all these other surgeries with all those other adjuvant treatments for cancer patients, I was always getting called, hey, you know, Mrs. Smith has red breasts now. She's being admitted for IV antibiotics in 24 hours. If she's not better, we're gonna have to take out her implant. I mean, that was a. That would happen when people were on chemotherapy. Yeah. So I come into your. Your office five years ago, and I'm interested. What are. What are the risks for me stepping into the implant space? Yeah. So I would have been, you know, if somebody only wants to go up a cup size, I would explain, you know, fat transfers to them. And then I would say, the risk benefit ratio for an implant doesn't make sense.